You are here

  • Home
  • Archive
  • Volume 76, Issue Suppl 2
  • SAT0161 Preliminary real world data on switching patterns between etanercept, its recently marketed biosimilar counterpart and its competitor adalimumab, using swedish prescription registry

Citation Tools

Article menu

Download PDFPDF

Poster Presentations
Rheumatoid arthritis - anti-TNF therapy
SAT0161 Preliminary real world data on switching patterns between etanercept, its recently marketed biosimilar counterpart and its competitor adalimumab, using swedish prescription registry
Free

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Alten R, Neregård P, Jones H, et al
SAT0161 Preliminary real world data on switching patterns between etanercept, its recently marketed biosimilar counterpart and its competitor adalimumab, using swedish prescription registry
Annals of the Rheumatic Diseases 2017;76:831.